Attempt to disqualify Baker Botts denied

A federal judge has denied Takeda Pharmaceuticals’ request that Baker Botts be disqualified from representing Zydus Pharmaceuticals in antitrust litigation against Takeda.

Get unlimited access to all Global Competition Review content